Spaces:
Running
Running
Rename proa/ginecologia.html to proa/guias/ginecologia.html
Browse files- proa/ginecologia.html +0 -140
- proa/guias/ginecologia.html +180 -0
proa/ginecologia.html
DELETED
|
@@ -1,140 +0,0 @@
|
|
| 1 |
-
<!DOCTYPE html>
|
| 2 |
-
<html lang="es">
|
| 3 |
-
<head>
|
| 4 |
-
<meta charset="UTF-8">
|
| 5 |
-
<meta name="viewport" content="width=device-width, initial-scale=1.0">
|
| 6 |
-
<title>Guía PROA - Infecciones Ginecológicas</title>
|
| 7 |
-
<script src="https://cdn.tailwindcss.com"></script>
|
| 8 |
-
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
|
| 9 |
-
<style>
|
| 10 |
-
@import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');
|
| 11 |
-
body { font-family: 'Montserrat', sans-serif; background-color: #f8fafc; }
|
| 12 |
-
.treatment-card { transition: all .3s ease; }
|
| 13 |
-
.treatment-card:hover { transform: translateY(-2px); box-shadow: 0 10px 15px -3px rgba(0,0,0,0.1),0 4px 6px -2px rgba(0,0,0,0.05); }
|
| 14 |
-
.custom-select { background-image: url("data:image/svg+xml,%3csvg xmlns='http://www.w3.org/2000/svg' fill='none' viewBox='0 0 20 20'%3e%3cpath stroke='%236b7280' stroke-linecap='round' stroke-linejoin='round' stroke-width='1.5' d='M6 8l4 4 4-4'/%3e%3c/svg%3e"); background-position: right .5rem center; background-repeat: no-repeat; background-size: 1.5em 1.5em; }
|
| 15 |
-
.treatment-option { background:white; border-left:4px solid #8b5cf6; border-radius:.5rem; padding:1rem; margin:1rem 0 .5rem; }
|
| 16 |
-
.treatment-title { font-weight:600; color:#5b21b6; margin-bottom:.5rem; display:flex; align-items:center; gap:.5rem; }
|
| 17 |
-
.note-box { background:#f3e8ff; border-left:4px solid #a78bfa; padding:.75rem; margin:1rem 0; border-radius:0 .5rem .5rem 0; }
|
| 18 |
-
.note-title { font-weight:600; color:#5b21b6; display:flex; align-items:center; gap:.5rem; margin-bottom:.5rem; }
|
| 19 |
-
ul { margin-left:1.25rem; } li { margin-bottom:.25rem; }
|
| 20 |
-
optgroup { font-style:italic; }
|
| 21 |
-
</style>
|
| 22 |
-
</head>
|
| 23 |
-
<body class="min-h-screen bg-gray-50">
|
| 24 |
-
<div class="max-w-4xl mx-auto px-4 py-8">
|
| 25 |
-
<div class="flex items-center gap-3 mb-6">
|
| 26 |
-
<div class="bg-purple-600 p-2 rounded-lg text-white"><i class="fas fa-female text-2xl"></i></div>
|
| 27 |
-
<h1 class="text-3xl font-bold text-gray-800">Guía PROA - Infecciones Ginecológicas</h1>
|
| 28 |
-
</div>
|
| 29 |
-
<div class="bg-white rounded-xl shadow p-6 mb-6">
|
| 30 |
-
<label for="sel" class="block text-lg font-medium text-gray-700 mb-2 flex items-center gap-2"><i class="fas fa-layer-group text-purple-500"></i> Seleccione categoría</label>
|
| 31 |
-
<select id="sel" class="custom-select block w-full pl-3 pr-10 py-2 border border-gray-300 rounded-md focus:ring-purple-500 focus:border-purple-500">
|
| 32 |
-
<option value="">-- Elige categoría --</option>
|
| 33 |
-
<optgroup label="Cervicitis">
|
| 34 |
-
<option value="cerv_sin">Sin etiología conocida</option>
|
| 35 |
-
<option value="cerv_gono">N. gonorrhoeae</option>
|
| 36 |
-
<option value="cerv_chlam">C. trachomatis</option>
|
| 37 |
-
</optgroup>
|
| 38 |
-
<optgroup label="Vulvovaginitis">
|
| 39 |
-
<option value="vulvo_candi">Candidiasis</option>
|
| 40 |
-
<option value="vulvo_vagino">Vaginosis bacteriana</option>
|
| 41 |
-
</optgroup>
|
| 42 |
-
<optgroup label="Úlceras genitales">
|
| 43 |
-
<option value="ulc_sif_pri">Sífilis <1 año</option>
|
| 44 |
-
<option value="ulc_sif_lat">Sífilis >1 año</option>
|
| 45 |
-
<option value="ulc_neuro">Neurosífilis</option>
|
| 46 |
-
</optgroup>
|
| 47 |
-
<option value="epi">Enfermedad Inflamatoria Pélvica</option>
|
| 48 |
-
<option value="verru">Verrugas genitales</option>
|
| 49 |
-
<option value="endo_sec">Endometritis secundaria</option>
|
| 50 |
-
</select>
|
| 51 |
-
</div>
|
| 52 |
-
<div id="result" class="space-y-6"></div>
|
| 53 |
-
<div id="store" class="hidden">
|
| 54 |
-
<!-- Cervicitis sin etiología conocida -->
|
| 55 |
-
<div id="cerv_sin" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 56 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Cervicitis (sin etiología conocida)</h2>
|
| 57 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Ceftriaxona 500 mg IM + Azitromicina 1 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
|
| 58 |
-
<div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Cefixima 400 mg VO + Azitromicina 2 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
|
| 59 |
-
<div class="treatment-option"><div class="treatment-title">Alergia</div><p>Azitromicina 2 g VO + Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
|
| 60 |
-
<div class="note-box"><div class="note-title">Observaciones</div><ul><li>Alta sospecha gonococo: Azitromicina preferente.</li></ul></div>
|
| 61 |
-
</div>
|
| 62 |
-
<!-- Cervicitis gonocócica -->
|
| 63 |
-
<div id="cerv_gono" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 64 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Cervicitis por N. gonorrhoeae</h2>
|
| 65 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Ceftriaxona 500 mg IM + Azitromicina 1 g VO.</p></div>
|
| 66 |
-
<div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Cefixima 400 mg VO + Azitromicina 2 g VO.</p></div>
|
| 67 |
-
<div class="treatment-option"><div class="treatment-title">Alergia</div><p>Azitromicina 2 g VO + Gentamicina 240 mg IV o Ciprofloxacino 500 mg VO.</p></div>
|
| 68 |
-
<div class="note-box"><div class="note-title">Observaciones</div><ul><li>Gonorrea puede diseminarse (conjuntivitis, artropatía).</li><li>Resistencia a quinolonas ≥50%.</li></ul></div>
|
| 69 |
-
</div>
|
| 70 |
-
<!-- Cervicitis por Chlamydia -->
|
| 71 |
-
<div id="cerv_chlam" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 72 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Cervicitis por C. trachomatis</h2>
|
| 73 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Azitromicina 1 g VO dosis única o Doxiciclina 100 mg/12 h VO ×7 d.</p></div>
|
| 74 |
-
<div class="note-box"><div class="note-title">Linfogranuloma venéreo</div><p>Doxiciclina 100 mg/12 h VO ×21 d o Azitromicina 1 g VO semanal ×3 semanas.</p></div>
|
| 75 |
-
</div>
|
| 76 |
-
<!-- Vulvovaginitis candidiasis -->
|
| 77 |
-
<div id="vulvo_candi" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 78 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Candidiasis Vulvovaginal</h2>
|
| 79 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Clotrimazol 500 mg óvulo único o 200 mg/24 h ×3 d; crema 1% ×7-14 d.</p></div>
|
| 80 |
-
<div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Fluconazol 15 mg VO dosis única.</p></div>
|
| 81 |
-
<div class="note-box"><div class="note-title">Recurrente / Embarazo</div><ul><li>Recurrente: Fluconazol 150 mg ×3, luego 150 mg semanal ×6 m.</li><li>Embarazadas: Clotrimazol 100 mg ×7 d.</li></ul></div>
|
| 82 |
-
</div>
|
| 83 |
-
<!-- Vulvovaginitis vaginosis -->
|
| 84 |
-
<div id="vulvo_vagino" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 85 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Vaginosis Bacteriana</h2>
|
| 86 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Metronidazol 500 mg VO/12 h ×7 d o gel 0.75% 5 g/24 h ×5 d.</p></div>
|
| 87 |
-
<div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Clindamicina crema 2% 5 g/24 h ×7 d.</p></div>
|
| 88 |
-
<div class="note-box"><div class="note-title">Observaciones</div><ul><li>No ITS, asociado mayor riesgo de ITS.</li></ul></div>
|
| 89 |
-
</div>
|
| 90 |
-
<!-- Úlceras genitales sífilis primaria -->
|
| 91 |
-
<div id="ulc_sif_pri" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 92 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Sífilis primaria/latente precoz</h2>
|
| 93 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Penicilina G benzatina 2.4 MUI IM dosis única.</p></div>
|
| 94 |
-
<div class="treatment-option"><div class="treatment-title">Alergia</div><p>Azitromicina 2 g VO o Doxiciclina 100 mg/12 h ×14 d.</p></div>
|
| 95 |
-
<div class="note-box"><div class="note-title">Embarazo</div><p>Eritromicina 500 mg/6 h ×14 d + Azitromicina 2 g.</p></div>
|
| 96 |
-
</div>
|
| 97 |
-
<!-- Úlceras sífilis latente tardía -->
|
| 98 |
-
<div id="ulc_sif_lat" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 99 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Sífilis latente tardía</h2>
|
| 100 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Penicilina G benzatina 2.4 MUI IM semanales ×3 semanas.</p></div>
|
| 101 |
-
<div class="treatment-option"><div class="treatment-title">Alergia</div><p>Doxiciclina 100 mg/12 h VO ×28 d.</p></div>
|
| 102 |
-
</div>
|
| 103 |
-
<!-- Neurosífilis -->
|
| 104 |
-
<div id="ulc_neuro" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 105 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Neurosífilis</h2>
|
| 106 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Penicilina G IV 3-4 MUI/4 h o 18-24 MUI infusión continua ×14 d.</p></div>
|
| 107 |
-
<div class="treatment-option"><div class="treatment-title">Alternativa</div><p>Ceftriaxona 2 g/24 h IV ×14 d.</p></div>
|
| 108 |
-
</div>
|
| 109 |
-
<!-- EPI -->
|
| 110 |
-
<div id="epi" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 111 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Enfermedad Inflamatoria Pélvica (EPI)</h2>
|
| 112 |
-
<div class="treatment-option"><div class="treatment-title">Ambulatorio</div><p>Ceftriaxona 0.5-1 g IM + Doxiciclina 100 mg/12 h VO ×14 d ± Metronidazol 500 mg/12 h ×14 d.</p></div>
|
| 113 |
-
<div class="treatment-option"><div class="treatment-title">Hospitalización</div><p>Doxiciclina 100 mg/12 h + Ceftriaxona 2 g + Metronidazol 500 mg/8 h IV ×14 d.</p></div>
|
| 114 |
-
<div class="note-box"><div class="note-title">Observaciones</div><ul><li>Hospitalizar en embarazo, absceso o mala respuesta.</li></ul></div>
|
| 115 |
-
</div>
|
| 116 |
-
<!-- Verrugas genitales -->
|
| 117 |
-
<div id="verru" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 118 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Verrugas Genitales</h2>
|
| 119 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Podofilotoxina 2 aplicaciones/d ×3 d/semana, Sinacatequinas 3 aplic/d ×16 sem, Imiquimod o 5-FU tópico.</p></div>
|
| 120 |
-
<div class="note-box"><div class="note-title">Observaciones</div><ul><li>No requiere estudio etiológico; derivar a dermato (crioterapia).</li></ul></div>
|
| 121 |
-
</div>
|
| 122 |
-
<!-- Endometritis secundaria -->
|
| 123 |
-
<div id="endo_sec" class="treatment-card bg-white rounded-lg shadow p-6 border border-gray-200">
|
| 124 |
-
<h2 class="text-2xl font-bold text-gray-800 mb-4">Endometritis Secundaria</h2>
|
| 125 |
-
<div class="treatment-option"><div class="treatment-title">De elección</div><p>Clindamicina 900 mg IV + Gentamicina 5 mg/kg/24 h IV hasta 48 h afebril.</p></div>
|
| 126 |
-
<div class="treatment-option"><div class="treatment-title">Alternativas</div><p>Amoxi/clav 6-8 h o Piperacilina/Tazobactam 4 g/6 h; Ceftriaxona 1 g/24 h + Metronidazol 500 mg/8 h.</p></div>
|
| 127 |
-
<div class="note-box"><div class="note-title">Observaciones</div><ul><li>Clinda preferible en lactancia.</li><li>Completar 7 d VO si bacteriemia.</li></ul></div>
|
| 128 |
-
</div>
|
| 129 |
-
</div>
|
| 130 |
-
<script>
|
| 131 |
-
const sel=document.getElementById('sel'), res=document.getElementById('result'), store=document.getElementById('store');
|
| 132 |
-
sel.addEventListener('change', ()=>{ res.innerHTML=''; const id=sel.value; if(!id) return; const node=store.querySelector('#'+id); if(node) res.appendChild(node.cloneNode(true)); });
|
| 133 |
-
</script>
|
| 134 |
-
<div class="mt-12 text-center text-sm text-gray-500">
|
| 135 |
-
<p>© 2025 Grupo PROA del Hospital de Alcañiz</p>
|
| 136 |
-
<p>Elaborado por Dr. Antonio J. Arnal Meinhardt | Médico de Urgencias</p>
|
| 137 |
-
</div>
|
| 138 |
-
</div>
|
| 139 |
-
</body>
|
| 140 |
-
</html>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
proa/guias/ginecologia.html
ADDED
|
@@ -0,0 +1,180 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<div id="cerv_sin" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 2 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-question-circle text-purple-500 fa-fw"></i> Cervicitis (sin etiología conocida)</h2>
|
| 3 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 4 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 5 |
+
<p class="text-base text-gray-700">Ceftriaxona 500 mg IM + Azitromicina 1 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p>
|
| 6 |
+
</div>
|
| 7 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 8 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
|
| 9 |
+
<p class="text-base text-gray-700">Cefixima 400 mg VO + Azitromicina 2 g VO o Doxiciclina 100 mg/12 h VO ×7 d.</p>
|
| 10 |
+
</div>
|
| 11 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 12 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
|
| 13 |
+
<p class="text-base text-gray-700">Azitromicina 2 g VO + Doxiciclina 100 mg/12 h VO ×7 d.</p>
|
| 14 |
+
</div>
|
| 15 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 16 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
|
| 17 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 18 |
+
<li>Alta sospecha gonococo: Azitromicina preferente.</li>
|
| 19 |
+
</ul>
|
| 20 |
+
</div>
|
| 21 |
+
</div>
|
| 22 |
+
|
| 23 |
+
<div id="cerv_gono" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 24 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-bacteria text-red-500 fa-fw"></i> Cervicitis por N. gonorrhoeae</h2>
|
| 25 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 26 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 27 |
+
<p class="text-base text-gray-700">Ceftriaxona 500 mg IM + Azitromicina 1 g VO.</p>
|
| 28 |
+
</div>
|
| 29 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 30 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
|
| 31 |
+
<p class="text-base text-gray-700">Cefixima 400 mg VO + Azitromicina 2 g VO.</p>
|
| 32 |
+
</div>
|
| 33 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 34 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
|
| 35 |
+
<p class="text-base text-gray-700">Azitromicina 2 g VO + Gentamicina 240 mg IV o Ciprofloxacino 500 mg VO.</p>
|
| 36 |
+
</div>
|
| 37 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 38 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
|
| 39 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 40 |
+
<li>Gonorrea puede diseminarse (conjuntivitis, artropatía).</li>
|
| 41 |
+
<li>Resistencia a quinolonas ≥50%.</li>
|
| 42 |
+
</ul>
|
| 43 |
+
</div>
|
| 44 |
+
</div>
|
| 45 |
+
|
| 46 |
+
<div id="cerv_chlam" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 47 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-viruses text-cyan-500 fa-fw"></i> Cervicitis por C. trachomatis</h2>
|
| 48 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 49 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 50 |
+
<p class="text-base text-gray-700">Azitromicina 1 g VO dosis única o Doxiciclina 100 mg/12 h VO ×7 d.</p>
|
| 51 |
+
</div>
|
| 52 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 53 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-biohazard text-red-600 fa-fw"></i> Linfogranuloma venéreo</div>
|
| 54 |
+
<p class="text-base text-gray-700">Doxiciclina 100 mg/12 h VO ×21 d o Azitromicina 1 g VO semanal ×3 semanas.</p>
|
| 55 |
+
</div>
|
| 56 |
+
</div>
|
| 57 |
+
|
| 58 |
+
<div id="vulvo_candi" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 59 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-pastafarianism text-orange-400 fa-fw"></i> Candidiasis Vulvovaginal</h2> <div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 60 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 61 |
+
<p class="text-base text-gray-700">Clotrimazol 500 mg óvulo único o 200 mg/24 h ×3 d; crema 1% ×7-14 d.</p>
|
| 62 |
+
</div>
|
| 63 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 64 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
|
| 65 |
+
<p class="text-base text-gray-700">Fluconazol 150 mg VO dosis única.</p> </div>
|
| 66 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 67 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-redo text-orange-500 fa-fw"></i> Recurrente / <i class="fas fa-baby text-pink-500 fa-fw"></i> Embarazo</div>
|
| 68 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 69 |
+
<li>Recurrente: Fluconazol 150 mg ×3, luego 150 mg semanal ×6 m.</li>
|
| 70 |
+
<li>Embarazadas: Clotrimazol 100 mg ×7 d.</li>
|
| 71 |
+
</ul>
|
| 72 |
+
</div>
|
| 73 |
+
</div>
|
| 74 |
+
|
| 75 |
+
<div id="vulvo_vagino" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 76 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-bacterium text-teal-500 fa-fw"></i> Vaginosis Bacteriana</h2>
|
| 77 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 78 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 79 |
+
<p class="text-base text-gray-700">Metronidazol 500 mg VO/12 h ×7 d o gel 0.75% 5 g/24 h ×5 d.</p>
|
| 80 |
+
</div>
|
| 81 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 82 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
|
| 83 |
+
<p class="text-base text-gray-700">Clindamicina crema 2% 5 g/24 h ×7 d.</p>
|
| 84 |
+
</div>
|
| 85 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 86 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
|
| 87 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 88 |
+
<li>No ITS, asociado mayor riesgo de ITS.</li>
|
| 89 |
+
</ul>
|
| 90 |
+
</div>
|
| 91 |
+
</div>
|
| 92 |
+
|
| 93 |
+
<div id="ulc_sif_pri" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 94 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fab fa-stripe-s text-red-600 fa-fw"></i> Sífilis primaria/latente precoz (<1 año)</h2>
|
| 95 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 96 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 97 |
+
<p class="text-base text-gray-700">Penicilina G benzatina 2.4 MUI IM dosis única.</p>
|
| 98 |
+
</div>
|
| 99 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 100 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
|
| 101 |
+
<p class="text-base text-gray-700">Azitromicina 2 g VO o Doxiciclina 100 mg/12 h ×14 d.</p>
|
| 102 |
+
</div>
|
| 103 |
+
<div class="note-box bg-pink-50 border-l-4 border-pink-400 p-3 mt-4 rounded-r-lg"> <div class="note-title text-base font-semibold text-pink-800 mb-1.5 flex items-center gap-2"><i class="fas fa-baby text-pink-500 fa-fw"></i> Embarazo</div>
|
| 104 |
+
<p class="text-base text-gray-700">Eritromicina 500 mg/6 h ×14 d + Azitromicina 2 g.</p>
|
| 105 |
+
</div>
|
| 106 |
+
</div>
|
| 107 |
+
|
| 108 |
+
<div id="ulc_sif_lat" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 109 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fab fa-stripe-s text-red-700 fa-fw"></i> Sífilis latente tardía (>1 año)</h2>
|
| 110 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 111 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 112 |
+
<p class="text-base text-gray-700">Penicilina G benzatina 2.4 MUI IM semanales ×3 semanas.</p>
|
| 113 |
+
</div>
|
| 114 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 115 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-allergies text-orange-500 fa-fw"></i> Alergia</div>
|
| 116 |
+
<p class="text-base text-gray-700">Doxiciclina 100 mg/12 h VO ×28 d.</p>
|
| 117 |
+
</div>
|
| 118 |
+
</div>
|
| 119 |
+
|
| 120 |
+
<div id="ulc_neuro" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 121 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-brain text-red-800 fa-fw"></i> Neurosífilis</h2>
|
| 122 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 123 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 124 |
+
<p class="text-base text-gray-700">Penicilina G IV 3-4 MUI/4 h o 18-24 MUI infusión continua ×14 d.</p>
|
| 125 |
+
</div>
|
| 126 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 127 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativa</div>
|
| 128 |
+
<p class="text-base text-gray-700">Ceftriaxona 2 g/24 h IV ×14 d.</p>
|
| 129 |
+
</div>
|
| 130 |
+
</div>
|
| 131 |
+
|
| 132 |
+
<div id="epi" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 133 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-female text-pink-600 fa-fw"></i> Enfermedad Inflamatoria Pélvica (EPI)</h2>
|
| 134 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 135 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-walking text-green-500 fa-fw"></i> Ambulatorio</div>
|
| 136 |
+
<p class="text-base text-gray-700">Ceftriaxona 0.5-1 g IM + Doxiciclina 100 mg/12 h VO ×14 d ± Metronidazol 500 mg/12 h ×14 d.</p>
|
| 137 |
+
</div>
|
| 138 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-red-600"> <div class="treatment-title text-base font-semibold text-red-800 mb-1.5 flex items-center gap-2"><i class="fas fa-hospital text-red-500 fa-fw"></i> Hospitalización</div>
|
| 139 |
+
<p class="text-base text-gray-700">Doxiciclina 100 mg/12 h + Ceftriaxona 2 g + Metronidazol 500 mg/8 h IV ×14 d.</p>
|
| 140 |
+
</div>
|
| 141 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 142 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
|
| 143 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 144 |
+
<li>Hospitalizar en embarazo, absceso o mala respuesta.</li>
|
| 145 |
+
</ul>
|
| 146 |
+
</div>
|
| 147 |
+
</div>
|
| 148 |
+
|
| 149 |
+
<div id="verru" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 150 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-disease text-gray-500 fa-fw"></i> Verrugas genitales</h2>
|
| 151 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 152 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 153 |
+
<p class="text-base text-gray-700">Podofilotoxina 2 aplicaciones/d ×3 d/semana, Sinacatequinas 3 aplic/d ×16 sem, Imiquimod o 5-FU tópico.</p>
|
| 154 |
+
</div>
|
| 155 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 156 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
|
| 157 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 158 |
+
<li>No requiere estudio etiológico; derivar a dermato (crioterapia).</li>
|
| 159 |
+
</ul>
|
| 160 |
+
</div>
|
| 161 |
+
</div>
|
| 162 |
+
|
| 163 |
+
<div id="endo_sec" class="treatment-card bg-white rounded-lg shadow-sm p-5 border border-gray-200 mb-6">
|
| 164 |
+
<h2 class="text-base font-bold text-gray-800 mb-3 flex items-center gap-2"><i class="fas fa-procedures text-pink-600 fa-fw"></i> Endometritis Secundaria</h2>
|
| 165 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 166 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-check-circle text-green-500 fa-fw"></i> De elección</div>
|
| 167 |
+
<p class="text-base text-gray-700">Clindamicina 900 mg IV + Gentamicina 5 mg/kg/24 h IV hasta 48 h afebril.</p>
|
| 168 |
+
</div>
|
| 169 |
+
<div class="treatment-option bg-white rounded-lg p-3 my-3 border-l-4 border-purple-600">
|
| 170 |
+
<div class="treatment-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-exchange-alt text-blue-500 fa-fw"></i> Alternativas</div>
|
| 171 |
+
<p class="text-base text-gray-700">Amoxi/clav 6-8 h o Piperacilina/Tazobactam 4 g/6 h; Ceftriaxona 1 g/24 h + Metronidazol 500 mg/8 h.</p>
|
| 172 |
+
</div>
|
| 173 |
+
<div class="note-box bg-purple-50 border-l-4 border-purple-400 p-3 mt-4 rounded-r-lg">
|
| 174 |
+
<div class="note-title text-base font-semibold text-purple-800 mb-1.5 flex items-center gap-2"><i class="fas fa-info-circle text-purple-500 fa-fw"></i> Observaciones</div>
|
| 175 |
+
<ul class="list-disc list-outside ml-5 text-base text-gray-700 space-y-1">
|
| 176 |
+
<li>Clinda preferible en lactancia.</li>
|
| 177 |
+
<li>Completar 7 d VO si bacteriemia.</li>
|
| 178 |
+
</ul>
|
| 179 |
+
</div>
|
| 180 |
+
</div>
|